JEMPERLI

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug JEMPERLI contains one active pharmaceutical ingredient (API):

1 Dostarlimab UNII P0GVQ9A4S5 - DOSTARLIMAB

Dostarlimab is a humanised mAb of the IgG4 isotype that binds to PD-1 receptors and blocks the interactions of binding with its ligands PD-L1 and PD-L2. The inhibition of PD-1 pathway-mediated immune response results in reactivation of T-cell function such as proliferation, cytokine production, and cytotoxic activity. Dostarlimab potentiates T-cell responses, including anti-tumour immuno responses through blockade of PD-1 binding to PD-L1 and PD-L2. Read about Dostarlimab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
JEMPERLI Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FF07	Dostarlimab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
Discover more medicines within L01FF07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1847314
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1211538001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 452871
Country: FR	Base de données publique des médicaments	Identifier(s): 64849607
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9019
Country: IT	Agenzia del Farmaco	Identifier(s): 049453018
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1092482
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100448832